Cargando…

HIV-1 infection in dendritic cells in HAART suppressed patients

Detalles Bibliográficos
Autores principales:	Maldonado, lrvin M, Almodóvar, Sharilyn, Marrero, Giselle, Colón, María del C, López, Juan C, Rosado, Jesús, Domínguez, Carlos, Herrera, René, Hill, Martin, Cornier, Alberto S, Lorenzo, Eric
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716859/ http://dx.doi.org/10.1186/1742-4690-3-S1-P39

Ejemplares similares

Isolation and purification of HIV-1 LTR circles from PBMCs for the analysis of episomal env sequences
por: González, Sandra, et al.
Publicado: (2006)

Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART
por: Lopez, Carlos A., et al.
Publicado: (2010)

Human immunodeficiency virus, herpes virus infections, and pulmonary vascular disease
por: Flores, Sonia C., et al.
Publicado: (2013)

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy
por: Ocasio-Rivera, Marinel, et al.
Publicado: (2020)

Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
por: Buzón, Maria J., et al.
Publicado: (2011)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Current use of statins reduces risk of HIV rebound on suppressive HAART
por: Drechsler, Henning, et al.
Publicado: (2017)

Factors associated with 10 years of continuous viral load suppression on HAART
por: Bello, Kathryn J., et al.
Publicado: (2016)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
por: Salami, O, et al.
Publicado: (2010)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

HAART, THE HEART AND THE POTENTIAL FOR INTERACTION
por: Coyle, Liam, et al.
Publicado: (2022)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

SUN-168 HAART-Induced Hyperglycemic Hyperosmolar Syndrome: A Rare Manifestation of HAART Therapy
por: Vora, Aarohi, et al.
Publicado: (2019)

1566 Factors Associated with 10 Years of Continuous HIV Viral Load Suppression on HAART
por: Bello, Kathryn, et al.
Publicado: (2014)

SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack
por: Evans, Nicholas, et al.
Publicado: (2021)

Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
por: Martinez, V, et al.
Publicado: (2006)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Premature and accelerated aging: HIV or HAART?
por: Smith, Reuben L., et al.
Publicado: (2013)

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
por: Rusconi, S, et al.
Publicado: (2010)

SARS-CoV-2 and HIV: Impact on Pulmonary Epithelial Cells
por: Evans, Nicholas J., et al.
Publicado: (2022)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment
por: Keiser, Philip H, et al.
Publicado: (2005)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study
por: Fekene, Tamirat Edie, et al.
Publicado: (2018)

Better quality of life with neuropsychological improvement on HAART
por: Parsons, Thomas D, et al.
Publicado: (2006)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

HAART and ATT in the HIV-positive patient with tuberculosis
por: Jhiens, Zi Z., et al.
Publicado: (2012)

Control of viral replication after cessation of HAART
por: Van Gulck, Ellen, et al.
Publicado: (2011)

HAART rollout in the new fiscal and economic environment
por: Moatti, J
Publicado: (2012)

HAART toxicity masquerading as a surgical abdomen
por: Feghali, Anthony, et al.
Publicado: (2015)

Changes in Lipid Indices in HIV+ Cases on HAART
por: Ji, Shujing, et al.
Publicado: (2019)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Anemia and Risk Factors in HAART Naïve and HAART Experienced HIV Positive Persons in South West Ethiopia: A Comparative Study
por: Gedefaw, Lealem, et al.
Publicado: (2013)

Human Polyomavirus-Associated Cerebral Disorders in the Post-HAART Era
por: Cedeno-Laurent, Filiberto, et al.
Publicado: (2011)

BK virus associated meningoencephalitis in an AIDS patient treated with HAART
por: Vidal, José E, et al.
Publicado: (2007)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

An altered cytotoxic program of CD8(+) T-cells in HIV-infected patients despite HAART-induced viral suppression
por: Perdomo-Celis, Federico, et al.
Publicado: (2019)

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort
por: Lifson, Alan R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uu7ssbhs9882pnoj13v6h68j9e